PHARMA EVIDENCE ApS: Financial statements 2019
CVR: 34586519
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PHARMA EVIDENCE ApS (CVR 34586519) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 749,320 and a net result of DKK 220,887 compared with DKK 123,447 the year before. That is a decrease of 32.9% compared with the year before. Equity in the 2019 report amounted to DKK 649,900. The solvency ratio was 70.2%.
- Gross Profit
- DKK 749,320
- Profit/Loss
- DKK 220,887
- Equity
- DKK 649,900
- Total Assets
- DKK 925,768
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 749 t. | 221 t. | 650 t. | - |
| 2018 | - | 1.1 mio. | 123 t. | 429 t. | - |
| 2017 | - | 625 t. | 280 t. | 306 t. | 1 |
| 2016 | - | -28 t. | -48 t. | 26 t. | - |
| 2015 | - | 255 t. | -154 t. | 73 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
PHARMA EVIDENCE ApS has published its annual report for 2018. Gross profit came to DKK 1,116,888, and the net result was DKK 123,447.
About PHARMA EVIDENCE ApS
PHARMA EVIDENCE ApS is a Danish company of the type Anpartsselskab based in Farum, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Tove Holm-Larsen. The company is owned by HB World Holding ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 64,007 and a net result of DKK 62,147 compared with DKK -179,749 the year before. Equity in the 2025 report amounted to DKK 134,401.